What is the current Global Gastroparesis Drug Market size?

The Global Gastroparesis Drug Market is projected to register a CAGR of 4.5% during the forecast period (2024-2029) Read More

Who are the key players in Global Gastroparesis Drug Market?

Evoke Pharma, AstraZeneca, Cadila Pharmaceuticals, Neurogastrx, Inc. and AbbVie Inc. ( Allergan Plc) are the major companies operating in the Global Gastroparesis Drug Market. Read More

Which is the fastest growing region in Global Gastroparesis Drug Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Global Gastroparesis Drug Market?

In 2024, the North America accounts for the largest market share in Global Gastroparesis Drug Market. Read More

What years does this Global Gastroparesis Drug Market cover?

The report covers the Global Gastroparesis Drug Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Gastroparesis Drug Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Global Gastroparesis Drug Market Share

Statistics for the 2023 & 2024 Global Gastroparesis Drug market share, created by Mordor Intelligence™ Industry Reports. Global Gastroparesis Drug share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Global Gastroparesis Drug Industry

The market is consolidated in nature due to the presence of very limited players operating globally. Some companies currently dominating the market are Abbott Laboratories (Abbott Arzneimittel GmbH), AbbVie Inc. (Allergan Plc), Cadila Pharmaceuticals, Evoke Pharma, AstraZeneca Plc, Neurogastrx Inc., Bausch Health, Theravance Biopharma, and GlaxoSmithKline Plc.